The Correlation Study of Hypnotic Drugs on the Cognitive Function of Patients With Chronic Insomnia.
NCT04996953, Unknown, Lili Cao
Trial 8
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | The Correlation Study of Hypnotic Drugs on the Cognitive Function of Patients With Chronic Insomnia. | ClinicalTrials.gov |
| NCT number | NCT04996953 | ClinicalTrials.gov |
| Status | Unknown | ClinicalTrials.gov |
| Enrollment | 165 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Lili Cao | ClinicalTrials.gov |
| Conditions | Insomnia Chronic | ClinicalTrials.gov |
| First posted | 2021-08-09 | ClinicalTrials.gov |
| Last updated | 2021-08-16 | ClinicalTrials.gov |
Registered outcomes 11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Pittsburgh sleep quality index scale | 1 day | The sleep quality of the patients in the past month was evaluated. The higher the score, the worse the sleep quality. The scale of the score is 0-21, and the higher score means a worse outcome. | ClinicalTrials.gov |
| Primary | Epworth Sleeping Scale | 1 day | Assess the possibility of dozing (not just feeling tired) in recent months. The higher the score was, the more likely it was to doze during the day. The scale of the score is 0-24, and the higher score means a worse outcome. | ClinicalTrials.gov |
| Primary | Insomnia Severity Index | 1 day | Liker scale is used to evaluate the nature and symptoms of sleep disorders. The higher the score, the more serious the insomnia. The scale of the score is 0-28, and the higher score means a worse outcome. | ClinicalTrials.gov |
| Primary | Hamilton Anxiety Scale | 1 day | It can be used to evaluate the depressive symptoms of depression, manic depression, neurosis and other diseases. The scale of the score is 0-56, and the higher score means a worse outcome. | ClinicalTrials.gov |
| Primary | Hamilton Depression Scale | 1 day | It can be used to evaluate the depressive symptoms of depression, manic depression, neurosis and other diseases. The higher the score, the more severe the depression. The scale of the score is 0-96, and the higher score means a worse outcome. | ClinicalTrials.gov |
| Primary | The Word Learning Scale | 1 day | used to evaluate the subjects from two aspects of immediate recall and long-term delayed recall. The evaluation content included 15 words in five categories: body parts, animals, tools, vehicles and furniture. The 15 words were first presented three times.The score of immediate recall was the total number of words recalled three times, and the score of short-term delay recall was the correct number of free recall after 2min.Among them, immediate memory lower than 18 indicates that immediate memory function is impaired, and delayed memory lower than 6 indicates that delayed memory is impaired.the higher scores mean a better outcome. | ClinicalTrials.gov |
| Primary | The verbal Fluency Scale | 1 day | They were asked to name as many animals, fruits and vegetables as possible in a 60-second experiment,the higher scores mean a better outcome. | ClinicalTrials.gov |
| Primary | The Numeral-Sign Conversion Test Scale | 1 day | The tester placed the test in front of the subject, with a number above it and a symbol below it, with a different symbol for each number.Subjects were given 90 seconds to fill each space with a symbol that matched the sample, and were given one point for each symbol that matched, the higher the score, the better. | ClinicalTrials.gov |
| Primary | Digital Span Test Scale | 1 day | To assess the subjects' attention span, forward and backward number spans were the subjects' ability to recite a series of numbers in the correct order.Participants were asked to repeat a series of random numbers in reverse order, reading each number for one second.Participants were asked to repeat the number in reverse order.Each set of numbers was randomly composed of the numbers 1 to 9, and the highest success score was calculated.The most successful scores were back-to-back 10 points and back-to-back 8 points.The higher the score, the better. | ClinicalTrials.gov |
| Primary | Stroop Color Word Test Scale | 1 day | The executive ability of the subjects was assessed by the number of questions correctly answered by the subjects within 1min, which was divided into three types of cards: A, B and C, and each card had 100 items.Subjects correctly read the total number of red, blue, and green color names printed in black on card A within 1min, correctly identify the total number of red, blue, and green color backgrounds on card B within 1min, and correctly read the total number of different colors with red, blue, and green names on card C within 1min.For all parts of the Stroop test, the result is the time required to complete the C-card task, and the correct number, which is a kind of executive function test.The longer it takes, the worse the result, the higher the correct number, the better. | ClinicalTrials.gov |
| Primary | Trail Making Test A and B Scale | 1 day | Test A: Show the numbers from 1 to 25. They are randomly distributed. Connect them in the order of 1, 2, 3, all the way to 25.Test B: There are numbers 1 to 13, black and white, respectively, in the order of the color black and white cameras, such as white 1 with black 1, black 1 with white 2, white 2 with black 2, all the way to 13.the higher scores mean a worse outcome. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 4
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Primary outcome | ConductCognition |
| Trail Making Test A | Primary outcome | ConductCognition |
| Trail Making Test B | Primary outcome | ConductCognition |
| Verbal Fluency | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)